A detailed history of Royce & Associates LP transactions in Atri Cure, Inc. stock. As of the latest transaction made, Royce & Associates LP holds 64,785 shares of ATRC stock, worth $1.98 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
64,785
Previous 59,985 8.0%
Holding current value
$1.98 Million
Previous $1.37 Million 33.04%
% of portfolio
0.02%
Previous 0.01%

Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 06, 2024

BUY
$20.34 - $29.5 $97,632 - $141,600
4,800 Added 8.0%
64,785 $1.82 Million
Q2 2024

Aug 13, 2024

BUY
$19.86 - $29.09 $407,189 - $596,432
20,503 Added 51.93%
59,985 $1.37 Million
Q1 2024

May 13, 2024

SELL
$28.21 - $37.78 $1.63 Million - $2.18 Million
-57,700 Reduced 59.37%
39,482 $1.2 Million
Q4 2023

Feb 12, 2024

SELL
$32.99 - $43.25 $16,495 - $21,625
-500 Reduced 0.51%
97,182 $3.47 Million
Q2 2023

Aug 07, 2023

SELL
$40.44 - $49.6 $12,132 - $14,880
-300 Reduced 0.31%
97,682 $4.82 Million
Q1 2023

May 04, 2023

SELL
$35.87 - $47.22 $107,609 - $141,660
-3,000 Reduced 2.97%
97,982 $4.06 Million
Q4 2022

May 23, 2023

BUY
$33.48 - $47.45 $100,439 - $142,350
3,000 Added 3.06%
100,982 $4.48 Million
Q2 2022

Aug 04, 2022

SELL
$35.1 - $66.01 $14,040 - $26,404
-400 Reduced 0.39%
100,982 $4.13 Million
Q1 2022

May 05, 2022

SELL
$57.43 - $71.39 $91,888 - $114,224
-1,600 Reduced 1.55%
101,382 $6.66 Million
Q4 2021

Feb 07, 2022

SELL
$63.4 - $87.14 $223,041 - $306,558
-3,518 Reduced 3.3%
102,982 $7.16 Million
Q3 2021

Nov 10, 2021

SELL
$69.28 - $84.46 $69,280 - $84,460
-1,000 Reduced 0.93%
106,500 $7.41 Million
Q2 2021

Aug 06, 2021

SELL
$64.13 - $80.18 $1.17 Million - $1.46 Million
-18,243 Reduced 14.51%
107,500 $8.53 Million
Q2 2020

Aug 07, 2020

SELL
$31.78 - $51.19 $1.4 Million - $2.26 Million
-44,200 Reduced 26.01%
125,743 $5.65 Million
Q1 2020

May 12, 2020

SELL
$24.49 - $43.84 $337,962 - $604,992
-13,800 Reduced 7.51%
169,943 $5.71 Million
Q4 2019

Feb 06, 2020

SELL
$24.06 - $32.51 $4,451 - $6,014
-185 Reduced 0.1%
183,743 $5.97 Million
Q3 2019

Nov 13, 2019

SELL
$23.81 - $32.52 $5.98 Million - $8.17 Million
-251,231 Reduced 57.73%
183,928 $4.59 Million
Q2 2019

Aug 12, 2019

BUY
$26.85 - $30.74 $1.52 Million - $1.74 Million
56,726 Added 14.99%
435,159 $13 Million
Q1 2019

May 09, 2019

BUY
$26.38 - $33.34 $941,766 - $1.19 Million
35,700 Added 10.42%
378,433 $10.1 Million
Q4 2018

Feb 11, 2019

SELL
$26.66 - $34.85 $232,261 - $303,613
-8,712 Reduced 2.48%
342,733 $10.5 Million
Q3 2018

Nov 13, 2018

SELL
$27.62 - $35.58 $2,762 - $3,558
-100 Reduced 0.03%
351,445 $12.3 Million
Q2 2018

Aug 09, 2018

BUY
$19.65 - $30.28 $14,658 - $22,588
746 Added 0.21%
351,545 $9.51 Million
Q1 2018

May 14, 2018

BUY
$15.05 - $21.03 $903,000 - $1.26 Million
60,000 Added 20.63%
350,799 $7.2 Million
Q4 2017

Feb 09, 2018

BUY
$17.69 - $23.44 $187,496 - $248,440
10,599 Added 3.78%
290,799 $5.3 Million
Q3 2017

Nov 13, 2017

SELL
$20.0 - $24.23 $444,000 - $537,906
-22,200 Reduced 7.34%
280,200 $6.27 Million
Q2 2017

Aug 07, 2017

BUY
N/A
302,400
302,400 $7.33 Million

Others Institutions Holding ATRC

About AtriCure, Inc.


  • Ticker ATRC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 46,424,700
  • Market Cap $1.42B
  • Description
  • AtriCure, Inc. develops, manufactures, and sells devices for the surgical ablation of cardiac tissue and systems, and intercostal nerves to medical centers in the United States, Europe, Asia, and internationally. The company offers Isolator Synergy Clamps, a single-use disposable radio frequency products; multifunctional pens and linear ablation...
More about ATRC
Track This Portfolio

Track Royce & Associates LP Portfolio

Follow Royce & Associates LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Royce & Associates LP, based on Form 13F filings with the SEC.

News

Stay updated on Royce & Associates LP with notifications on news.